1. Home
  2. CRSP vs MGY Comparison

CRSP vs MGY Comparison

Compare CRSP & MGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$46.38

Market Cap

4.4B

Sector

Health Care

ML Signal

N/A

Logo Magnolia Oil & Gas Corporation

MGY

Magnolia Oil & Gas Corporation

N/A

Current Price

$31.49

Market Cap

5.2B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
CRSP
MGY
Founded
2013
2017
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
5.2B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
CRSP
MGY
Price
$46.38
$31.49
Analyst Decision
Buy
Buy
Analyst Count
17
13
Target Price
$70.29
$28.17
AVG Volume (30 Days)
2.0M
2.7M
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
2.15%
EPS Growth
N/A
N/A
EPS
N/A
0.24
Revenue
$289,590,000.00
$1,311,845,000.00
Revenue This Year
$1,082.59
$0.70
Revenue Next Year
$87.74
$9.46
P/E Ratio
N/A
$127.81
Revenue Growth
9169.85
N/A
52 Week Low
$30.06
$19.09
52 Week High
$78.48
$31.21

Technical Indicators

Market Signals
Indicator
CRSP
MGY
Relative Strength Index (RSI) 38.40 78.62
Support Level N/A $22.97
Resistance Level $60.63 N/A
Average True Range (ATR) 2.30 0.72
MACD -0.84 0.11
Stochastic Oscillator 10.22 97.48

Price Performance

Historical Comparison
CRSP
MGY

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About MGY Magnolia Oil & Gas Corporation

Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area of South Texas, where it targets the Eagle Ford Shale and Austin Chalk formations. It focuses on generating value for shareholders by delivering steady, moderate annual production growth resulting from its capital spending philosophy. The company operates in only one segment and derives the majority of its revenue from the sale of crude oil, natural gas, and natural gas liquids (NGLs).

Share on Social Networks: